Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02377050 · ClinicalTrials.gov registry record · NA

Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates

A NA study of Infant, Premature, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT02377050: Completed NA study of Infant, Premature, sponsored by University of Alabama at Birmingham.

NCT02377050 is a NA study of Infant, Premature that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 224 participants, below the 9,873-participant average among 16 other Infant, Premature trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02377050, a NA study of Infant, Premature, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

The primary hypothesis is that preterm infants who are less than or equal to 32 weeks gestation and weigh 1001-2500 grams at birth will have an increase in weight gain with a feeding goal of 180-200 ml/kg/day more than the commonly used feeding goal of 140-160 ml/kg/day

Primary Outcome

Average change in weight between baseline and 12 weeks

Conditions Studied

Interventions

  • OTHER Higher Volume Feeding Goal

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2015-01
Est. Completion 2018-06
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT02377050 record still lists

NCT02377050 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 9,873-participant average among 16 other Infant, Premature trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Infant, Premature appearing as the primary indexed condition, and to 1 intervention - of which Higher Volume Feeding Goal is the first listed.

NCT02377050 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT02377050 about?

NCT02377050 is a clinical study titled "Randomized Controlled Trial of Higher-Volume Feedings in Preterm Neonates". The primary hypothesis is that preterm infants who are less than or equal to 32 weeks gestation and weigh 1001-2500 grams at birth will have an increase in weight gain with a feeding goal of 180-200 ml/kg/day more than the commonly used feeding goal of 140-160 ml/kg/day

What is the current status of trial NCT02377050?

This trial is currently completed. It is a NA study. The enrollment target is 224 participants. The study started on 2015-01. Estimated completion is 2018-06.

What conditions does trial NCT02377050 study?

This clinical trial studies the following conditions: Infant, Premature.

What interventions are being tested in trial NCT02377050?

The interventions under investigation include: Higher Volume Feeding Goal (OTHER).

Who is sponsoring clinical trial NCT02377050?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02377050 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant, Premature

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02377050's enrollment target sits among peer trials

224 12th of 16 higher than 5 of 16 other Infant, Premature trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infant, Premature trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04140344 · 224 participants · NA

    The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05519878 · 224 participants · NA

    Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02377050, the US trial registry maintained by the National Library of Medicine. NCT02377050 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.